DigiPharm 2013 conference, October 8-10, London

Date: Sep-30-2013Healthcare organisations that once focused on developing products or delivering services - often independently - must now come together to deliver improved health solutions and patient outcomes. Life sciences companies are chief among the health organisations expected to deliver this change.

One of the key catalysts and tools to this change is the evolution of digital communication and engagement with patients and prescribers. Industry experts are saying that there is an opportunity for the pharmaceutical industry to enhance and support the relationship between healthcare and patients and that improved engagement can help better manage disease and improve outcomes.

DigiPharm 2013, with an outstanding agenda and speaker panel, will be addressing the opportunities and challenges presented by new technologies. Critical issues that are to discussed include: the changing commercial model of pharma, patient engagement, and compliance and clinical dilemmas. DigiPharm takes place in London at the Guoman Tower Hotel on the 8th - 10th October 2013.

To help set the scene for DigiPharm 2013, we asked some industry experts 'what they think the future holds for digital in pharma.'

Corrine Pilgrim, EMEA Product Director, Janssen. 'For me the real opportunity is interaction with patients and carers, because I think that before digital, we really couldn't communicate effectively with them and I think now we've got a great opportunity via the digital channels to do so, obviously in an appropriate way. It has opened up a whole new method of communication.'

Andy Burke, Sales Director, eMedFusion. 'I think at the moment there is a lot of talk about multi channel and digital platforms, so I think it's about aligning everything, so it's all built within the same technology, and I think making sure that everything is compliant and hopefully building on the social media channels.'

Shona Davies, Global Unbranded Portals CoE Project Leader, MSD. 'I think that obviously there is a lot of technologies out there that people are looking at trialing, and seeing how it all works. I think the most important from a pharma point of view is going to be how we integrate digital formats nto our everyday marketing activity rather than keeping it as a separate part of what we do as organisations and really making it part of a marketers day to day life.'

To hear the opinions of other leading experts including:
Ragnar gseby, Global head Multi-Channel Marketing, Merck
Suzanna Van Straaten, Associate Director Commercial effectiveness, Genzyme
Peter Aksel Viiadsen, Director Global Patient Engagement, Leo Pharma



& many more, you should attend DigiPharm 2013.

To find out more visit http://www.healthnetworkcommunications.com/2013/digipharm/
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.